2015 Newsletter Archive

January 2015

Alzheimer’s Advocate vol. 82

ACT-AD Meeting on Combination Therapy Featured in Expert Review of Neurotherapeutics

Volunteers Can Make a Difference for Alzheimer’s Research

ACT-AD Sterling Silver Sponsor of February NIH Alzheimer’s Research Summit

Pat Summitt Alzheimer’s Clinic to Open in Tennessee

New MRI Technique Detects Early Alzheimer’s

Insulin Spray May Improve Memory in Dementia Patients

Issues Related to Heart and Stroke Contribute to Dementia


February 2015

Alzheimer’s Advocate vol. 83

Q & A with Anavex President and CEO Missling

ACT-AD Responds to 21st Century Cures Legislation

NIH Alzheimer’s Research Summit Available for Viewing

ACT-AD Meeting on Combination Therapy Featured in Expert Review of Neurotherapeutics

‘SuperAgers’ Research Could Offer Hope for Alzheimer’s Patients

Conversation with FDA Commissioner Dr. Margaret Hamburg

Dietary Advanced Glycation End Products Could Increase Alzheimer’s Risk, Says Study

Alzheimer’s Association Releases New Report on AD Trajectory

‘Rebalancing’ of Immune Cells Could Fight Alzheimer’s


March 2015

Alzheimer’s Advocate vol. 84

FDA Commissioner Hamburg Addresses Budget and Medical Innovation

FDA to Hold Workshops on Endpoints and Regulatory Science

U.K. Government Announces Creation of Dementia Discovery Fund

Simple Blood Test Could Detect Beta Amyloid Proteins, Say Experts

16-Year-Old’s Alzheimer’s Device Featured at White House Science Fair

New Novel Approach to Treating Inherited Alzheimer’s Explored by Experts

Website Offers Comprehensive Info for Alzheimer’s Prevention Research


April 2015

Alzheimer’s Advocate vol. 85

ACT-AD Holds Webinar on Novel Targets for AD Treatment

ACT-AD Calls for $200 Million Increase in FY 2016 Appropriated Funding for FDA

NIA Seeks Volunteers for Alzheimer’s Disease Clinical Trials

ACT-AD Science Advisory Board Member Dr. Reisa Sperling and A4 Study Featured in Prevention Magazine

Senate Committee Hearings on Innovation Continue

NIH Puts Focus on Alzheimer’s Disease

MIND Diet May Reduce Risk of AD

Cancer Drug May Offer Hope to Alzheimer’s Disease Patients

Deprivation of Nutrient Arginine Could Cause AD


May 2015

Alzheimer’s Advocate vol. 86

ACT-AD Offers Comment on 21st Century Cures Bill

ICYMI: ACT-AD Webinar on Novel Targets for AD Treatment Available

Recommendations on NIH Summit Released

ACT-AD To Take Part in BIO International Convention

New Report on International Forum to Advance AD
Research Released

Peptide D8 Offers Potential Early Intervention
for Alzheimer’s Disease

Aspiring Scientist Takes on AD

Comprehensive New Study on Cognitive Aging Released

A Connection between AD and Diabetes?


June 2015

Alzheimer’s Advocate vol. 87

SAVE THE DATE: ACT-AD FDA/AD Allies Meeting Set for September 16

ACT-AD Part of Two Sessions at BIO Convention

ACT-AD’s Bens to Participate in FDA PDUFA July 15 Meeting

New Report Covers Role of Caregiver in the U.S.

Impact Factor of Journal of Alzheimer’s Disease Increases 15 Percent

Treatment That Protects Against Organ Transplant Rejection May Also Protect Against AD

Amyloid Precursor Protein May Play Role in Eye and Muscle Health


July 2015

Alzheimer’s Advocate vol. 88

ACT-AD Executive Director Testifies at Key FDA Meetings

SAVE THE DATE: ACT-AD FDA/AD Allies Meeting Set for September 16

Alzheimer’s Association International Conference Held This Month

ACT-AD Member to Host 16th International Conference on Alzheimer’s Drug Discovery

FDA Report on Collaboration and Research Needed to Develop Cures

An Update on Policy of Use of Single IRB for Multisite Research


August 2015

Alzheimer’s Advocate vol. 89

Register Now for the ACT-AD FDA/AD Allies Meeting!

ACT-AD Executive Director Speaks at PDUFA Briefing on September 2

ACT-AD Member Hosts International Conference on Alzheimer’s Drug Discovery, October 5-6

An Examination of Medical Costs Due to AD Misdiagnosis among Medicare Beneficiaries

Experts ID Risk Factors That May Lead to Development of AD

MIND Diet May Slow Cognitive Decline, Say Researchers

Study Finds Age Affects the Brain’s Ability to Dispose of Amyloid Beta Protein


September 2015

Alzheimer’s Advocate vol. 90

ACT-AD Eighth Annual Meeting a Great Success

New Resource from the Alzheimer’s Foundation of America

FDA Holds PDUFA Stakeholder Meeting

AD Clinical Trials Enroll First Patient

Alzheimer’s Researcher Tanzi Honored by Alliance for Aging Research

New Study Finds Alzheimer’s Disease Composed of Three Distinct Subtypes

Researchers Seek to Find Brain’s Progression to Dementia


October 2015

Alzheimer’s Advocate vol. 91

ICYMI: ACT-AD’s FDA/AD Allies Meeting Recap

Status of FY 2016 FDA Funding Still Up in the Air

Updates on PDUFA and MDUFA

FDA Updates Report on Areas of Progress and Continuing Challenges

New Members Added to HHS Alzheimer’s Advisory Council

AFA Holds Auction to Raise Awareness about Programs

Expert Tanzi Talks Alzheimer’s Research

Experts Make Discovery into the Role of Microglia in Development of AD

The Promise of Small Heat Shock Proteins


November 2015

Alzheimer’s Advocate vol. 92

Senate Committee Considers FDA Commissioner Nomination

FDA Hosts Workshop on Neurodiagnostics

FDA Continues Monthly Stakeholder Consultation on PDUFA and MDUFA

Conference on Alzheimer’s Disease-Related Dementias, March 29-30, 2016

New Paper on ‘Current Dementia R&D Landscape’

NIH Starts Initiative on Alzheimer’s Disease and Down Syndrome

November 1-7 Was National Memory Screening Week

New Infographic on the Impact of Alzheimer’s Disease Research

Experts Say Immune System in Brain Could Help Remove Amyloid Plaques


December 2015

Alzheimer’s Advocate vol. 93

Congress Passes FY 2016 Appropriations Bill, Good News for Alzheimer’s Disease Research

Stakeholder Consultation on FDA User Fee Reauthorization Continues, ACT-AD Represented

ACT-AD Executive Director Joins Panel on FDA and Patient Centeredness

NIA Releases Alzheimer’s Disease Progress Report

New Study Finds Anti-Androgen Drugs Could Be Linked to Increased Alzheimer’s Disease Risk

Experts Examine Connection between Gait Speed and Alzheimer’s Disease

Negative Beliefs about Aging Could Contribute to Development of Alzheimer’s Disease, Say Yale Experts